HSBC made the call as it listed the pharma stocks it sees as best positioned to play a recovery in the sector.

Novo Nordisk is expanding discounted retail options for consumers who want to purchase the weight-loss medications Wegovy and ...

Vltava Fund, an investment management company, recently released its third-quarter 2025 investor letter. A copy of the letter ...

Costco will sell a 4-week supply of Ozempic or Wegovy for $499 out-of-pocket for customers with a valid prescription.

Get this week's top healthcare stock movers, market trends, and exclusive updates on key pharma deals and drug pricing.

COPENHAGEN: Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to reignite growth and fend off intense competition from U.S. rival Eli ...

The move comes after the wholesale club partnered with Novo Nordisk, the manufacturer of the popular weight-loss and diabetes ...

President Donald Trump announced Tuesday that his administration has reached a deal with Pfizer for it to voluntarily sell ...

Pfizer Inc. Chief Executive Albert Bourla said the company secured a three-year grace period from President Trump’s promised ...

The Trump administration reportedly wants to offer prescription medicines at a discount directly from pharmaceutical companies ...

(Reuters) - The U.S. Food and Drug Administration issued warning letters to Eli Lilly, Novo Nordisk and telehealth firm Hims & Hers Health last week as part of President Donald Trump's order to crack ...